AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people
AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people worldwide and 30,000 in the US as company signs £15million manufacturing deal Thousands volunteers already being injected with jab in UK, Brazil, South Africa Preliminary data from phase 3 trials expected ‘soon’, said lead jab researcher Developers say they hope to deliver the… Read More »